169 related articles for article (PubMed ID: 27604155)
1. Molecular basis of antibody-mediated neutralization and protection against flavivirus.
Dai L; Wang Q; Qi J; Shi Y; Yan J; Gao GF
IUBMB Life; 2016 Oct; 68(10):783-91. PubMed ID: 27604155
[TBL] [Abstract][Full Text] [Related]
2. The role of anti-flavivirus humoral immune response in protection and pathogenesis.
Hurtado-Monzón AM; Cordero-Rivera CD; Farfan-Morales CN; Osuna-Ramos JF; De Jesús-González LA; Reyes-Ruiz JM; Del Ángel RM
Rev Med Virol; 2020 Jul; 30(4):e2100. PubMed ID: 32101633
[TBL] [Abstract][Full Text] [Related]
3. A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.
Pierson TC; Diamond MS
Prog Mol Biol Transl Sci; 2015; 129():141-66. PubMed ID: 25595803
[TBL] [Abstract][Full Text] [Related]
4. Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity.
VanBlargan LA; Goo L; Pierson TC
Microbiol Mol Biol Rev; 2016 Dec; 80(4):989-1010. PubMed ID: 27784796
[TBL] [Abstract][Full Text] [Related]
5. Cross-Reactive Flavivirus Antibody: Friend and Foe?
Maciejewski S; Pierson TC
Cell Host Microbe; 2018 Nov; 24(5):622-624. PubMed ID: 30439339
[TBL] [Abstract][Full Text] [Related]
6. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development.
Pierson TC; Fremont DH; Kuhn RJ; Diamond MS
Cell Host Microbe; 2008 Sep; 4(3):229-38. PubMed ID: 18779049
[TBL] [Abstract][Full Text] [Related]
7. The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.
Rey FA; Stiasny K; Vaney MC; Dellarole M; Heinz FX
EMBO Rep; 2018 Feb; 19(2):206-224. PubMed ID: 29282215
[TBL] [Abstract][Full Text] [Related]
8. Screening and identification of B-cell epitopes within envelope protein of tembusu virus.
Zhao D; Han K; Huang X; Zhang L; Wang H; Liu N; Tian Y; Liu Q; Yang J; Liu Y; Li Y
Virol J; 2018 Sep; 15(1):142. PubMed ID: 30223850
[TBL] [Abstract][Full Text] [Related]
9. A Novel Neutralizing Antibody Targeting a Unique Cross-Reactive Epitope on the hi Loop of Domain II of the Envelope Protein Protects Mice against Duck Tembusu Virus.
Chen X; Li C; Lin W; Li T; Li X; Bai X; Wulin S; Zhang Q; Li S; Liu M; Liu JH; Zhang Y
J Immunol; 2020 Apr; 204(7):1836-1848. PubMed ID: 32132180
[TBL] [Abstract][Full Text] [Related]
10. Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques.
McCracken MK; Gromowski GD; Friberg HL; Lin X; Abbink P; De La Barrera R; Eckles KH; Garver LS; Boyd M; Jetton D; Barouch DH; Wise MC; Lewis BS; Currier JR; Modjarrad K; Milazzo M; Liu M; Mullins AB; Putnak JR; Michael NL; Jarman RG; Thomas SJ
PLoS Pathog; 2017 Aug; 13(8):e1006487. PubMed ID: 28771605
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Neutralizing Monoclonal Antibody That Recognizes a Unique Epitope on Domain III of the Envelope Protein of Tembusu Virus.
Qu S; Wang X; Yang L; Lv J; Meng R; Dai W; Li Q; Liu H; Zhang B; Zhang D
Viruses; 2020 Jun; 12(6):. PubMed ID: 32549221
[TBL] [Abstract][Full Text] [Related]
12. Antibody-mediated neutralization of flaviviruses: a reductionist view.
Dowd KA; Pierson TC
Virology; 2011 Mar; 411(2):306-15. PubMed ID: 21255816
[TBL] [Abstract][Full Text] [Related]
13. Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody.
Dai L; Song J; Lu X; Deng YQ; Musyoki AM; Cheng H; Zhang Y; Yuan Y; Song H; Haywood J; Xiao H; Yan J; Shi Y; Qin CF; Qi J; Gao GF
Cell Host Microbe; 2016 May; 19(5):696-704. PubMed ID: 27158114
[TBL] [Abstract][Full Text] [Related]
14. Protective immune response against newly emerging goose tembusu virus infection induced by immunization with a recombinant envelope protein.
Zhao D; Huang X; Han K; Liu Y; Yang J; Liu Q; An F; Li Y
Lett Appl Microbiol; 2015 Oct; 61(4):318-24. PubMed ID: 26108865
[TBL] [Abstract][Full Text] [Related]
15. Mapping the diverse structural landscape of the flavivirus antibody repertoire.
Sevvana M; Kuhn RJ
Curr Opin Virol; 2020 Dec; 45():51-64. PubMed ID: 32801077
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection.
Pierson TC; Diamond MS
Expert Rev Mol Med; 2008 May; 10():e12. PubMed ID: 18471342
[TBL] [Abstract][Full Text] [Related]
17. Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner.
Mehlhop E; Ansarah-Sobrinho C; Johnson S; Engle M; Fremont DH; Pierson TC; Diamond MS
Cell Host Microbe; 2007 Dec; 2(6):417-26. PubMed ID: 18078693
[TBL] [Abstract][Full Text] [Related]
18. Epitope analysis of the envelope and non-structural glycoproteins of Murray Valley encephalitis virus.
Hall RA; Kay BH; Burgess GW; Clancy P; Fanning ID
J Gen Virol; 1990 Dec; 71 ( Pt 12)():2923-30. PubMed ID: 1703213
[TBL] [Abstract][Full Text] [Related]
19. CD4 T cell responses to flaviviruses.
Aberle JH; Koblischke M; Stiasny K
J Clin Virol; 2018 Nov; 108():126-131. PubMed ID: 30312909
[TBL] [Abstract][Full Text] [Related]
20. Impact of viral attachment factor expression on antibody-mediated neutralization of flaviviruses.
Obara CJ; Dowd KA; Ledgerwood JE; Pierson TC
Virology; 2013 Mar; 437(1):20-7. PubMed ID: 23312596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
